204 related articles for article (PubMed ID: 29075110)
1. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
[TBL] [Abstract][Full Text] [Related]
2. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
3. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.
Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ
Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
[TBL] [Abstract][Full Text] [Related]
8. iTEP nanoparticle-delivered salinomycin displays an enhanced toxicity to cancer stem cells in orthotopic breast tumors.
Zhao P; Dong S; Bhattacharyya J; Chen M
Mol Pharm; 2014 Aug; 11(8):2703-12. PubMed ID: 24960465
[TBL] [Abstract][Full Text] [Related]
9. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
[TBL] [Abstract][Full Text] [Related]
10. An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.
Zhao P; Xia G; Dong S; Jiang ZX; Chen M
Biomaterials; 2016 Jul; 93():1-9. PubMed ID: 27060212
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells.
Oak PS; Kopp F; Thakur C; Ellwart JW; Rapp UR; Ullrich A; Wagner E; Knyazev P; Roidl A
Int J Cancer; 2012 Dec; 131(12):2808-19. PubMed ID: 22511343
[TBL] [Abstract][Full Text] [Related]
12. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Zhou J; Sun J; Chen H; Peng Q
Int J Oncol; 2018 Sep; 53(3):1289-1300. PubMed ID: 30015824
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.
Yu Z; Chen F; Qi X; Dong Y; Zhang Y; Ge Z; Cai G; Zhang X
Exp Ther Med; 2018 Feb; 15(2):1247-1256. PubMed ID: 29399118
[TBL] [Abstract][Full Text] [Related]
14. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
15. Promoted Delivery of Salinomycin to Lung Cancer Through Epidermal Growth Factor Receptor Aptamers Coupled DSPE-PEG2000 Nanomicelles.
Leng D; Hu J; Huang X; He W; Wang Y; Liu M
J Nanosci Nanotechnol; 2018 Aug; 18(8):5242-5251. PubMed ID: 29458573
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
18. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
[TBL] [Abstract][Full Text] [Related]
19. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells.
Zhu M; Chen S; Hua L; Zhang C; Chen M; Chen D; Dong Y; Zhang Y; Li M; Song X; Chen H; Zheng H
Nanomedicine (Lond); 2017 Feb; 12(4):295-315. PubMed ID: 28093940
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HER2-Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2-Glycan-Imprinted Nanoparticles.
Dong Y; Li W; Gu Z; Xing R; Ma Y; Zhang Q; Liu Z
Angew Chem Int Ed Engl; 2019 Jul; 58(31):10621-10625. PubMed ID: 31166063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
